Farhad Pishgar1, Ali Guermazi2, Amir Ashraf-Ganjouei3, Arya Haj-Mirzaian4, Frank W Roemer2,5, Bashir Zikria6, Christopher Sereni7, Michael Hakky8, Shadpour Demehri4. 1. Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, 601 N Caroline St, JHOC 3142, Baltimore, MD, 21287, USA. Farhad.Pishgar@JHMI.edu. 2. Department of Radiology, VA Boston Healthcare System, Boston University School of Medicine, Boston, MA, USA. 3. Non-communicable Diseases Research Center, Endocrinology and Metabolism Population Science Institute, Tehran University of Medical Sciences, Tehran, Iran. 4. Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, 601 N Caroline St, JHOC 3142, Baltimore, MD, 21287, USA. 5. Department of Radiology, University of Erlangen-Nuremberg, Erlangen, Germany. 6. Department of Orthopaedic Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA. 7. Department of Radiology, University of Massachusetts Medical School, Boston, MA, USA. 8. Department of Radiology, Florida Hospital, Maitland, FL, USA.
Abstract
OBJECTIVES: To investigate the associations of medial and lateral patellofemoral osteoarthritis (PF-OA) at baseline with symptomatic and radiographic OA outcomes in the medial tibiofemoral compartment (MTFC) over 4 years, according to baseline overweight status. METHODS: Data and MRI images of 600 subjects in the FNIH-OA biomarkers consortium were used. Symptomatic worsening and radiographic progression of MTFC-OA were defined using Western Ontario and McMaster Universities Arthritis Index (WOMAC) pain scores and MTFC joint space narrowing (JSN) from baseline to 4-year follow-up. Baseline MRIs were read to establish PF-OA diagnosis. The association between baseline regional PF-OA pattern and odds for MTFC-OA progression was evaluated using regression models (adjusted for relevant confounding covariates including body mass index (BMI), age, sex, PF alignment measurements, KL grade, and knee alignment). To evaluate the effect modifying role for overweight status, stratification analysis was performed (BMI ≥ 25 vs. < 25 kg/m2). RESULTS: At baseline, 340 (56.7%), 255 (42.5%), and 199 (33.2%) subjects had OA in the medial, lateral, and both PF compartments. Baseline medial PF-OA was associated with WOMAC pain score and MTFC JSN progression at 4 years (Adjusted OR:1.56[95%CI:1.09-2.23] and 1.59[1.11-2.28], respectively) but not lateral PF-OA. In stratification analysis, overweight status was found to be an effect modifier for medial PF-OA and WOMAC pain (OR in overweight vs. non-overweight subjects:1.65[1.13-2.42] vs. 0.50[0.12-1.82]) as well as MTFC-JSN progression (1.63[1.12-2.4] vs. 0.75[0.19-2.81]). CONCLUSIONS: In addition to the known confounding effect of BMI for PF-OA and MTFC-OA, the overweight status may also play an effect modifier role in the association between baseline medial PF-OA and MTFC-OA progression, which is amenable to secondary prevention.
OBJECTIVES: To investigate the associations of medial and lateral patellofemoral osteoarthritis (PF-OA) at baseline with symptomatic and radiographic OA outcomes in the medial tibiofemoral compartment (MTFC) over 4 years, according to baseline overweight status. METHODS: Data and MRI images of 600 subjects in the FNIH-OA biomarkers consortium were used. Symptomatic worsening and radiographic progression of MTFC-OA were defined using Western Ontario and McMaster Universities Arthritis Index (WOMAC) pain scores and MTFC joint space narrowing (JSN) from baseline to 4-year follow-up. Baseline MRIs were read to establish PF-OA diagnosis. The association between baseline regional PF-OA pattern and odds for MTFC-OA progression was evaluated using regression models (adjusted for relevant confounding covariates including body mass index (BMI), age, sex, PF alignment measurements, KL grade, and knee alignment). To evaluate the effect modifying role for overweight status, stratification analysis was performed (BMI ≥ 25 vs. < 25 kg/m2). RESULTS: At baseline, 340 (56.7%), 255 (42.5%), and 199 (33.2%) subjects had OA in the medial, lateral, and both PF compartments. Baseline medial PF-OA was associated with WOMAC pain score and MTFC JSN progression at 4 years (Adjusted OR:1.56[95%CI:1.09-2.23] and 1.59[1.11-2.28], respectively) but not lateral PF-OA. In stratification analysis, overweight status was found to be an effect modifier for medial PF-OA and WOMAC pain (OR in overweight vs. non-overweight subjects:1.65[1.13-2.42] vs. 0.50[0.12-1.82]) as well as MTFC-JSN progression (1.63[1.12-2.4] vs. 0.75[0.19-2.81]). CONCLUSIONS: In addition to the known confounding effect of BMI for PF-OA and MTFC-OA, the overweight status may also play an effect modifier role in the association between baseline medial PF-OA and MTFC-OA progression, which is amenable to secondary prevention.
Authors: Arya Haj-Mirzaian; Ali Guermazi; Nima Hafezi-Nejad; Christopher Sereni; Michael Hakky; David J Hunter; Bashir Zikria; Frank W Roemer; Shadpour Demehri Journal: Eur Radiol Date: 2018-04-12 Impact factor: 5.315
Authors: Weiya Zhang; Daniel F McWilliams; Sarah L Ingham; Sally A Doherty; Stella Muthuri; Kenneth R Muir; Michael Doherty Journal: Ann Rheum Dis Date: 2011-05-25 Impact factor: 19.103
Authors: Frank W Roemer; Yuqing Zhang; Jingbo Niu; John A Lynch; Michel D Crema; Monica D Marra; Michael C Nevitt; David T Felson; Laura B Hughes; George Y El-Khoury; Martin Englund; Ali Guermazi Journal: Radiology Date: 2009-07-27 Impact factor: 11.105
Authors: Frank W Roemer; Ali Guermazi; Jamie E Collins; Elena Losina; Michael C Nevitt; John A Lynch; Jeffrey N Katz; C Kent Kwoh; Virginia B Kraus; David J Hunter Journal: BMC Musculoskelet Disord Date: 2016-11-10 Impact factor: 2.362